SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : C3 ( CTHR ) Diamond in the rough?
CTHR 0.400+700.0%Oct 31 12:16 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Leslie S. Feinberg who wrote (77)3/5/1998 2:04:00 PM
From: RagTimeBand  Read Replies (1) of 226
 
>>Did you see the news yesterday?<< For anyone who hasn't seen the headline:

Wednesday March 4, 8:33 am Eastern Time
Company Press Release

C3 Secures Patent for Lab-Created Moissanite Gemstones

MORRISVILLE, N.C.--(BUSINESS WIRE)--March 4, 1998--C3 Inc. (Nasdaq NM: CTHR - news), a developer of moissanite gemstones, a proprietary, lab-created alternative to diamond, today announced that the U.S. Patent and Trademark Office has issued C3 a patent for silicon carbide gemstones.

Complete story at: biz.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext